<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Google Introduces AlphaGenome: AI Model to Better Understand Human DNA - ABC News</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', 'Roboto', 'Helvetica Neue', Arial, sans-serif;
            line-height: 1.7;
            color: #333;
            background-color: #f8f9fa;
        }

        /* Header */
        .header {
            background-color: #1e40af;
            color: white;
            padding: 1rem 0;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
            position: sticky;
            top: 0;
            z-index: 100;
        }

        .header-content {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 2rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .logo {
            font-size: 1.8rem;
            font-weight: bold;
            text-decoration: none;
            color: white;
        }

        .back-button {
            background-color: rgba(255, 255, 255, 0.2);
            color: white;
            padding: 0.5rem 1rem;
            text-decoration: none;
            border-radius: 5px;
            transition: background-color 0.3s;
        }

        .back-button:hover {
            background-color: rgba(255, 255, 255, 0.3);
        }

        /* Article Container */
        .article-container {
            max-width: 800px;
            margin: 2rem auto;
            padding: 0 2rem;
        }

        /* Article Header */
        .article-header {
            background: white;
            border-radius: 12px;
            padding: 2rem;
            margin-bottom: 2rem;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
        }

        .article-category {
            display: inline-block;
            background-color: #7c3aed;
            color: white;
            padding: 0.5rem 1rem;
            font-size: 0.9rem;
            font-weight: bold;
            border-radius: 20px;
            margin-bottom: 1rem;
        }

        .article-title {
            font-size: 2.5rem;
            font-weight: bold;
            color: #1f2937;
            margin-bottom: 1rem;
            line-height: 1.2;
        }

        .article-subtitle {
            font-size: 1.2rem;
            color: #6b7280;
            margin-bottom: 1.5rem;
            line-height: 1.5;
        }

        .article-meta {
            display: flex;
            gap: 2rem;
            color: #9ca3af;
            font-size: 0.9rem;
            padding-top: 1rem;
            border-top: 1px solid #e5e7eb;
        }

        /* Featured Image */
        .featured-image {
            width: 100%;
            height: 400px;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            border-radius: 12px;
            margin-bottom: 2rem;
            display: flex;
            align-items: center;
            justify-content: center;
            color: white;
            font-size: 1.2rem;
            font-weight: bold;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
        }

        /* Article Content */
        .article-content {
            background: white;
            border-radius: 12px;
            padding: 2rem;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
            margin-bottom: 2rem;
        }

        .article-content p {
            margin-bottom: 1.5rem;
            font-size: 1.1rem;
        }

        .article-content h2 {
            font-size: 1.5rem;
            color: #1f2937;
            margin: 2rem 0 1rem 0;
            padding-bottom: 0.5rem;
            border-bottom: 2px solid #7c3aed;
        }

        .quote {
            background-color: #f3f4f6;
            border-left: 4px solid #7c3aed;
            padding: 1rem 1.5rem;
            margin: 2rem 0;
            font-style: italic;
            font-size: 1.1rem;
        }

        .highlight-box {
            background: linear-gradient(135deg, #667eea15, #764ba215);
            border: 1px solid #7c3aed30;
            border-radius: 8px;
            padding: 1.5rem;
            margin: 2rem 0;
        }

        .highlight-box h3 {
            color: #7c3aed;
            margin-bottom: 1rem;
        }

        /* Related Articles */
        .related-articles {
            background: white;
            border-radius: 12px;
            padding: 2rem;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
        }

        .related-articles h3 {
            font-size: 1.3rem;
            color: #1f2937;
            margin-bottom: 1rem;
        }

        .related-link {
            display: block;
            padding: 1rem 0;
            border-bottom: 1px solid #e5e7eb;
            text-decoration: none;
            color: #1e40af;
            transition: color 0.3s;
        }

        .related-link:hover {
            color: #7c3aed;
        }

        .related-link:last-child {
            border-bottom: none;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .article-title {
                font-size: 2rem;
            }

            .article-container {
                padding: 0 1rem;
            }

            .article-header,
            .article-content,
            .related-articles {
                padding: 1.5rem;
            }

            .article-meta {
                flex-direction: column;
                gap: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <!-- Header -->
    <header class="header">
        <div class="header-content">
            <a href="/" class="logo">ABC News</a>
        </div>
    </header>

    <!-- Article Container -->
    <div class="article-container">
        <!-- Article Header -->
        <div class="article-header">
            <span class="article-category">TECHNOLOGY</span>
            <h1 class="article-title">
                Google Introduces AlphaGenome: AI Model to Better Understand Human DNA
            </h1>
            <p class="article-subtitle">
                The new AI system advances regulatory variant-effect prediction and promises breakthrough insights into genome function, available for non-commercial research.
            </p>
            <div class="article-meta">
                <span>By Tech Reporter</span>
                <span>August 25, 2025</span>
                <span>847K views</span>
                <span>1 day ago</span>
            </div>
        </div>

        <!-- Featured Image -->
        <div class="featured-image">
            <div>AlphaGenome: AI-Powered DNA Analysis</div>
        </div>

        <!-- Article Content -->
        <div class="article-content">
            <p>
                Google has unveiled AlphaGenome, a groundbreaking artificial intelligence model designed to decode the complexities of human DNA with unprecedented accuracy. This innovative system represents a significant leap forward in computational biology, promising to revolutionize our understanding of genetic variants and their effects on human health.
            </p>

            <p>
                The announcement, made during Google's AI research showcase, positions AlphaGenome as a unifying DNA sequence model that could accelerate scientific discovery in genomics, drug development, and personalized medicine. The system is now available in preview through Google's AlphaGenome API for non-commercial research purposes.
            </p>

            <div class="highlight-box">
                <h3>What Makes AlphaGenome Special?</h3>
                <p>
                    Unlike previous genomic analysis tools, AlphaGenome integrates multiple types of biological data to create a comprehensive understanding of DNA function. The system can predict the effects of genetic variants with remarkable precision, potentially identifying disease-causing mutations before they manifest clinically.
                </p>
            </div>

            <h2>Revolutionary Approach to Genome Analysis</h2>

            <p>
                Traditional genetic analysis has long struggled with the challenge of regulatory variantsâ€”DNA changes that don't directly alter protein sequences but can dramatically affect gene expression. AlphaGenome addresses this critical gap by incorporating advanced machine learning techniques that can predict how these subtle genetic variations impact cellular function.
            </p>

            <p>
                The model has been trained on vast datasets of genomic information, including reference genomes, population genetics data, and functional genomics experiments. This comprehensive training allows AlphaGenome to understand context-dependent effects of genetic variants across different tissues and developmental stages.
            </p>

            <div class="quote">
                "AlphaGenome represents our commitment to advancing scientific research through AI. We believe this tool will significantly accelerate the pace of genomic discovery and help researchers worldwide tackle some of humanity's most challenging health problems," said a Google Research spokesperson.
            </div>

            <h2>Implications for Medical Research</h2>

            <p>
                The potential applications of AlphaGenome extend far beyond basic research. Medical geneticists anticipate that the system could transform clinical practice by enabling more accurate interpretation of genetic test results, particularly for rare diseases where traditional analysis methods often fall short.
            </p>

            <p>
                Pharmaceutical companies are also expressing keen interest in AlphaGenome's capabilities. The system could accelerate drug discovery by helping identify novel therapeutic targets and predicting how genetic variations might affect drug response in different populations.
            </p>

            <h2>Advancing Cancer Research</h2>

            <p>
                One of the most promising applications lies in cancer genomics, where understanding the functional impact of tumor-specific mutations is crucial for developing targeted therapies. AlphaGenome's ability to predict variant effects could help oncologists select more effective treatments based on individual patients' genetic profiles.
            </p>

            <p>
                Early collaborative studies have already demonstrated the model's potential in identifying previously unknown cancer-driving mutations, opening new avenues for therapeutic intervention.
            </p>

            <h2>Open Science Commitment</h2>

            <p>
                In keeping with Google's commitment to open science, AlphaGenome is being made available to the global research community through the AlphaGenome API. Academic researchers can access the system free of charge for non-commercial purposes, with plans to release the full model in the future.
            </p>

            <p>
                This approach mirrors the successful rollout of other Google AI tools like AlphaFold, which has transformed protein structure prediction and been adopted by researchers worldwide.
            </p>

            <div class="highlight-box">
                <h3>Getting Started with AlphaGenome</h3>
                <p>
                    Researchers interested in accessing AlphaGenome can apply through Google's research platform. The preview version includes comprehensive documentation, example datasets, and tutorial materials to help scientists integrate the tool into their existing workflows.
                </p>
            </div>

            <h2>Looking to the Future</h2>

            <p>
                As AlphaGenome continues to evolve, researchers expect it to become an indispensable tool in the genomics toolkit. The model's ability to provide insights into genome function could accelerate progress toward precision medicine, where treatments are tailored to individual genetic profiles.
            </p>

            <p>
                The scientific community is already planning collaborative projects to validate and extend AlphaGenome's capabilities, with particular focus on underrepresented populations and rare genetic disorders where current understanding remains limited.
            </p>
        </div>


    </div>

    <script>
        // Simple click tracking
        document.querySelectorAll('.related-link').forEach(link => {
            link.addEventListener('click', function(e) {
                e.preventDefault();
                console.log('Related article clicked:', this.textContent);
            });
        });
    </script>
</body>
</html>
